Objective: The aim of this study is to identify the clinical characteristics in adolescents newly diagnosed with ADHD. Method: Data of patients aged 7 to 17 years diagnosed with ADHD were collected and analyzed. The patients were divided into adolescents aged 13 to 17 years (Group I) and children aged 7 to 12 years (Group II): 592 males and 231 females. Group I consists of 450 participants, and Group II consists of 373 participants. Results: Adolescents were predominantly inattentive (63.8%); most of Group II patients had combined or hyperactive ADHD (70.8%). Learning disorders were more common in adolescents (51.2% vs. 39.7%) and treated mainly with long-acting methylphenidate (MPH), and Group II patients were treated mainly with short- and medium-acting MPH. Newly diagnosed adolescents were less likely to exhibit behavioral comorbidities. Headache and insomnia were reported more in adolescents, and stimulant rebound effect was more in younger children. Conclusion: Although the biological nature of ADHD is similar in both age groups, the primary symptomatology and associated comorbidities are prone to age-dependent changes.
AlbersL.von KriesR.HeinenF.StraubeA. (2015). Headache in school children: Is the prevalence increasing?Current Pain & Headache Reports, 19, Article 4. doi:10.1007/s11916-015-0477-0
2.
American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.
3.
American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., text rev.). Washington, DC: Author.
4.
American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Arlington, VA: American Psychiatric Publishing.
5.
BarkleyR. A.FischerM.SmallishL.FletcherK. (2002). The persistence of attention-deficit/hyperactivity disorder into young adulthood as a function of reporting source and definition of disorder. Journal of Abnormal Psychology, 111, 279-289.
6.
BiedermanJ.MickE.FaraoneS. V. (2000). Age-dependent decline of symptoms of attention deficit hyperactivity disorder: Impact of remission definition and symptom type. American Journal of Psychiatry, 157, 816-818.
7.
BuitelaarJ.MedoriR. (2010). Treating attention-deficit/hyperactivity disorder beyond symptom control alone in children and adolescents: A review of the potential benefits of long-acting stimulants. European Child & Adolescent Psychiatry, 19, 325-340. doi:10.1007/s00787-009-0056-1
8.
ByrdA. L.LoeberR.PardiniD. A. (2012). Understanding desisting and persisting forms of delinquency: The unique contributions of disruptive behavior disorders and interpersonal callousness. Journal of Child Psychology and Psychiatry, 53, 371-380. doi:10.1111/j.1469-7610.2011.02504
9.
CarissimiA.DreschF.MartinsA. C.LevandovskiR. M.AdanA.NataleV.. . . HidalgoM. P. (2016). The influence of school time on sleep patterns of children and adolescents. Sleep Medicine, 19, 33-39. doi:10.1016/j.sleep.2015.09.024
10.
FaraoneS.BiedermanJ.MickE. (2006). The age-dependent decline of attention deficit hyperactivity disorder: A meta-analysis of follow-up studies. Psychological Medicine, 36, 159-165.
11.
FendrichK.VennemannM.PfaffenrathV.EversS.MayA.BergerK.HoffmannW. (2007). Headache prevalence among adolescents—The German DMKG headache study. Cephalalgia, 27, 347-354.
12.
GeniziJ.GordonS.KeremN. C.SrugoI.ShaharE.RavidS. (2013). Primary headaches, attention deficit disorder and learning disabilities in children and adolescents. The Journal of Headache and Pain, 27(14), Article 54. doi:10.1186/1129-2377-14-54
13.
GoyetteC. H.ConnersC. K.UlrichR. F. (1978). Normative data on revised Conners Parent and Teacher Rating Scales. Journal of Abnormal Child Psychology, 6, 221-236.
14.
HarveyE. A.BreauxR. P.Lugo-CandelasC. I. (2015). Early development of comorbidity between symptoms of attention deficit hyperactivity disorder and oppositional defiant disorder. Journal of Abnormal Psychology, 125, 154-167. doi:10.1037/abn0000090
15.
HillJ. C.ScohenerH. P. (1996). Age-dependent decline of attention deficit hyperactivity disorder. American Journal of Psychiatry, 153, 1143-1146.
16.
HolbrookJ. R.CuffeS. P.CaiB.VisserS. N.ForthoferM. S.BottaiM.. . . McKeownR. E. (2016). Persistence of parent-reported ADHD symptoms from childhood through adolescence in a community sample. Journal of Attention Disorders, 20, 11-20. doi:10.1177/1087054714539997
17.
KaramR. G.BredaV.PiconF. A.RovarisD. L.VictorM. M.SalgadoC. A. I.… CayeA. (2015). Persistence and remission of ADHD during adulthood: A 7-year clinical follow-up study. Psychological Medicine, 45(10), 2045-2056.
18.
LaheyB. B.LeeS. S.SibleyM. H.ApplegateB.MolinaB. S.PelhamW. E. (2016). Predictors of adolescent outcomes among 4-6-year-old children with attention-deficit/hyperactivity disorder. Journal of Abnormal Psychology, 152, 168-181. doi:10.1037/abn0000086
19.
LangbergJ. M.EpsteinJ. N.AltayeM.MolinaB. S.ArnoldL. E.VitielloB. (2008). The transition to middle school is associated with changes in the developmental trajectory of ADHD symptomatology in young adolescents with ADHD. Journal of Clinical Child & Adolescent Psychology, 37, 651-663. doi:10.1080/15374410802148095
20.
LeckmanJ. F.ZhangH.VitaleA.LahninF.LynchK.BondiC.. . . PetersonB. S. (1998). Course of tic severity in Tourette syndrome: The first two decades. Pediatrics, 102, 14-19.
21.
LycettK.SciberrasE.HiscockH.MensahF. K. (2016). Sleep problem trajectories and well-being in children with attention-deficit hyperactivity disorder: A prospective cohort study. Journal of Developmental & Behavioral Pediatrics, 37, 405-414. doi:10.1097/DBP.0000000000000276
22.
MahajnahM.SharkiaR.ZelnikN. (2016). The clinical profile of ADHD in Israel—Impact of ethnic and social diversities. Israel Medical Association Journal, 18, 322-325.
23.
MannuzzaS.KleinR.BesslerA.MalloyP.LaPadulaM. (1998). Adult psychiatric status of hyperactive boys grown up. American Journal of Psychiatry, 155, 493-498.
24.
McKeownR. E.HolbrookJ. R.DanielsonM. L.CuffeS. P.WolraichM. L.VisserS. N. (2015). The impact of case definition on attention-deficit/hyperactivity disorder prevalence estimates in community-based samples of school-aged children. Journal of the American Academy of Child & Adolescent Psychiatry, 54, 53-61. doi:10.1016/j.jaac.2014.10.014.
25.
Rivas-JuesasC.de DiosJ. G.Benac-PrefaciM.Colomer-RevueltaJ. (2017). Analysis of the factors linked to a diagnosis of attention deficit hyperactivity disorder in children. Neurologia, 27(14), R713-R715. doi:10.1016/j.nrl.2016.01.006
26.
ShawM.HodgkinsP.CaciH.YoungS.KahleJ.WoodsA. G.ArnoldL. E. (2012). A systematic review and analysis of long-term outcomes in attention deficit hyperactivity disorder: Effects of treatment and non-treatment. BMC Medicine, 10, Article 99. doi:10.1186/1741-7015-10-99
27.
SteeleM.WeissM.SwansonJ.WangJ.PrinzoR. S.BinderC. E. (2006). A randomized, controlled effectiveness trial of OROS-methylphenidate compared to usual care with immediate-release methylphenidate in attention deficit-hyperactivity disorder. The Canadian Journal of Clinical Pharmacology, 13, e50-e62.
28.
ThomasR.SandersS.DoustJ.BellerE.GlasziouP. (2015). Prevalence of attention deficit/hyperactivity disorder: A systematic review and meta-analysis. Pediatrics, 135, e994-e1001. doi:10.1542/peds.2014-3482
29.
TuvbladC.ZhengM.RaineA.BakerL. A. (2009). A common genetic factor explains the covariation among ADHD ODD and CD symptoms in 9-10 year old boys and girls. Journal of Abnormal Child Psychology, 37, 153-167. doi:10.1007/s10802-008-9278-9
30.
Vande VoortJ. L.HeJ. P.JamesonN. D.MerikangasK. R. (2014). Impact of the DSM-5 attention-deficit/hyperactivity disorder age-of-onset criterion in the US adolescent population. Journal of the American Academy of Child & Adolescent Psychiatry, 53, 736-744. doi:10.1016/j.jaac.2014.03.005
31.
van LieshoutM.LumanM.TwiskJ. W.van EwijkH.GroenmanA. P.ThissenA. J.. . . OosterlaanJ. (2016). A 6-year follow-up of a large European cohort of children with attention-deficit/hyperactivity disorder-combined subtype: Outcomes in late adolescence and young adulthood. European Child & Adolescent Psychiatry, 25, 1007-1017.
32.
VisserS. N.DanielsonN. L.BitskoR. H.HolbrookJ. R.KoganM. D.GhandourR. M.. . . BlumbergS. J. (2014). Trends in the parent-report of health care provider-diagnosed and medicated attention-deficit/hyperactivity disorder: United States, 2003-2011. Journal of the American Academy of Child & Adolescent Psychiatry, 53, 33-46. doi:10.1016/j.jaac.2013.09.001
33.
WillcuttE. G. (2012). The prevalence of DSM-IV attention-deficit/hyperactivity disorder: A meta-analytic review. Neurotherapeutics, 9, 490-499. doi:10.1007/s13311-012-0135-8
